VCYT Stock Analysis: Buy, Sell, or Hold?
VCYT - Veracyte, Inc.
$38.90
0.65 (1.70%)
▲
5d:
-4.56%
30d:
+14.28%
90d:
+10.67%
BUY
MODERATE Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: May 12, 2026
0d
Get Alerted When VCYT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: VCYT shows positive signals but monitor for confirmation. Market pricing in 3.9% decline. Moderate conviction.
💡 BUY OPPORTUNITY: VCYT shows positive signals but monitor for confirmation. Market pricing in 3.9% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$52.89
Based on 4.2% avg growth
INTRINSIC VALUE TODAY
$32.84
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 22.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: VCYT is currently trading at $38.90, which is considered extended relative to its 30-day fair value range of $31.64 to $37.72. From a valuation perspective, the stock is trading at a discount (Forward PE: 20.1) compared to its historical average (22.6). Remarkably, the market is currently pricing in an annual earnings decline of 3.9% over the next few years. This pessimistic expectation contrasts with the company's recent 288.9% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, VCYT is in a strong downtrend. Immediate support is located at $32.13, while resistance sits at $42.10.
Market Sentiment: VCYT has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $47.40 (+23.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, VCYT is in a strong downtrend. Immediate support is located at $32.13, while resistance sits at $42.10.
Market Sentiment: VCYT has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $47.40 (+23.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$31.64 -
$37.72
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
61.9%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 23.9% below Wall St target ($47.40)
Trading Range Analysis
30-Day Trading Range
$31.64 -
$37.72
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$32.13
Resistance Level
$42.10
Current Trend
Strong Downtrend
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
20.08
Wall Street Target
$47.40
(+23.9%)
Revenue Growth (YoY)
21.5%
Earnings Growth (YoY)
288.9%
Profit Margin
16.2%
Valuation Discount vs History
-3.9% cheaper
PE vs Historical
20.1 vs 22.6
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-3.9%
(market-implied from PE analysis)
1-Year Target
$36.76
(-4%)
2-Year Target
$35.32
(-8%)
3-Year Target
$33.95
(-11%)
3-Yr Target (if PE normalizes)
(PE: 20→23)
$38.21
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.0, Growth: 4.4%)
$47.83
(+25%)
Base:
(SPY PE: 20.1, Growth: 4.4%)
$43.58
(+14%)
Bear:
(PE: 17.1, Growth: 4.4%)
$37.04
(-3%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (35x PE), but valuation improves significantly next year (20x PE) as earnings recover.
Trailing PE: 35.49 | Current EPS (TTM): $1.08
Bull Case
$74.37
(+94%)
Analyst growth 76.4%, PE expands to 39.0
Base Case
$67.61
(+77%)
Market implied 76.4%, PE stable at 35.5
Bear Case
$26.06
(-32%)
Severe decline -20.0%, PE contracts to 30.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 20.1 to 22.6
Stabilization Target:
$43.05
(+12.6%)
PE Expansion Potential:
+12.6%
Share & Embed Analysis
Last updated: May 14, 2026 4:33 PM ET
Data refreshes hourly during market hours. Next update: 5:33 PM
Data refreshes hourly during market hours. Next update: 5:33 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VCYT showing a specific setup today?
Insider Activity (6 Months)
1
Buys
13
Sells
Net
INSIDERS SELLING
Recent Transactions
John Leite
SELL
5260 shares
2026-03-04
Marc Stapley
SELL
45523 shares
2026-03-04
Rebecca Chambers
SELL
18341 shares
2026-03-04
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$620 | 55 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$250 | 58 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$130 | 59 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$261 | 58 HOLD |
